Microcirculation
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Jerusalem PharmaceuticalsIsrael - Ramallah
2 programsOmnilux new-UN/A1 trial
Photobiomodulation - Blue WavelengthN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Jerusalem PharmaceuticalsPhotobiomodulation - Blue Wavelength
Jerusalem PharmaceuticalsOmnilux new-U
Clinical Trials (2)
Total enrollment: 60 patients across 2 trials
The Effect of Photobiomodulation on Microvascular Blood Flow: The Role of Wavelength and Skin Temperature
Start: Jan 2026Est. completion: Dec 202840 patients
N/AEnrolling By Invitation
Evaluation of Peripheral Microcirculation Hemodynamics Following Various Changes Based on Noninvasive Thermography
Start: Nov 2017Est. completion: Dec 201920 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space